|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effects of ubiquinone ( coenzyme Qt0 ) on myopathy in statin users显示文摘 | Sehaars CF Stalenhoef AF | 2008 | Curt Opin Lipido12008，19，6： | 1 |
| 2 | Efficacy and Safety of a novel cholesteryl ester transfer protein inhibitor,JTT-705,in humans:a randomized phase dose-response study显示文摘 | de Grooth GJ Kuivenhoven JA Stalenhoef AF | 2002 | Circulation2002，105，18： | 1 |
| 3 | Enhanced susceptibility to in vitro oxidation of the dense low-density lipoprotein subfraction in healthy subjects显示文摘 | Hak-Lemmers HL Hectors MP Demacker PN Hendriks JC Stalenhoef AF | 1991 | Arterioscler Thromb1991，11，2： | 1 |
| 4 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor,JTT-705,in humans:a randomized phase Ⅱ dose-response study显示文摘 | de Grooth GJ Kuivenhoven JA Stalenhoef AF | 2002 | Circulation2002，105，18： | 1 |
| 5 | Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia显示文摘 | De Knijff P Stalenhoef AF Mol MJ | 1990 | Atherosclerosis1990，83，1： | 1 |
| 6 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor,JTT-705,in humans:a randomized phaseⅡdoseresponse study显示文摘 | Kuivenhoven JA Stalenhoef AF | 2002 | Circulation2002，105，18： | 1 |
| 7 | Efficacy and safety of a novel chotesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase Ⅱ doseresponse study显示文摘 | de GROOTH GJ KUIVENHOVEN JA STALENHOEF AF | 2002 | Circulation2002，105，18： | 1 |
| 8 | Plasma lipopro- teins, apolipoproteins, and triglyceride metabolism in familial hypertriglyceridemia显示文摘 | Stalenhoef AF Demacker PN Lutterman JA | 1986 | Arteriosclerosis1986，6，4： | 1 |
| 9 | Influence of contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol concentrations显示文摘 | DEMACKER PN SCHADE RW STALENHOEF AF | 1982 | Br Med J (Clin Res Ed)1982，284，6324： | 1 |
| 10 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase Ⅱ dose-response study显示文摘 | de GROOTH GJ KUIVENHOVEN JA STALENHOEF AF | 2002 | Circulation2002，105，18： | 1 |
| 11 | Serum triglycerides and risk of cardiovascular disease显示文摘 | Boullart AC de Graaf J Stalenhoef AF | 2012 | Biochim Biophys Acta2012，1821，5： | 1 |
| 12 | Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant - like lipoproteins and small dense LDL 显示文摘 | Stalenhoef AF De Graaf J | 2008 | Current Opinion in Lipidology2008，19，4： | 1 |
| 13 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor,JTT-705,in humans:a randomized phase Ⅱ dose-response study显示文摘 | de Grooth GJ Kuivenhoven JA Stalenhoef AF de Graaf J Zwinderman AH Posma JL | 2002 | Circulation2002，105，： | 1 |
| 14 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705 ,in humans:a randomized phase Ⅱ dose-response study显示文摘 | Kuivenhoven JA Stalenhoef AF | 2002 | Circulation2002，105，18： | 1 |
| 15 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT- 705 ,in humansa: randomized phase Ⅱ doseresponse study 显示文摘 | De Grooth G J Kuivenhoven JA Stalenhoef AF | 2002 | Grculation2002，105，18： | 1 |
| 16 | The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemina 显示文摘 | Stalenhoef AF Graaf J Wittekoek ME | 2000 | Atherosclerosis2000，153，1： | 1 |
| 17 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705,in humans: a randomized phase Ⅱ doee-response study显示文摘 | de Grooth GJ Kuivenhoven JA Stalenhoef AF | 2002 | Circulation2002，105，18： | 1 |
| 18 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase Ⅱ dose-response study显示文摘 | de GROOTH GJ KUIVENHOVEN JA STALENHOEF AF | 2002 | Circulation2002，105，18： | 1 |
| 19 | Diagnostic criteria in relation to the pathogenesis of familial combined hyperlipidemia 显示文摘 | de Graaf J van der Vleuten G Stalenhoef AF | 2004 | Semin Vasc Med2004，4，3： | 1 |
| 20 | Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor,JTT-705,in humans:a randomized phase II dose-response study显示文摘 | de Grooth GJ Kuivenhoven JA Stalenhoef AF | 2002 | Circulation2002，105，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员